Tracking Cathie Wood's ARK Invest 13F Portfolio - Q4 2025 Update
Source: SeekingAlpha
2026-02-12 22:37:04 ET
This article is part of a series that provides an ongoing analysis of the changes made to ARK Invest’ 13F portfolio on a quarterly basis. It is based on their regulatory 13F Form filed on 02/11/2026....
Read the full article on Seeking Alpha
For further details see:
Tracking Cathie Wood's ARK Invest 13F Portfolio - Q4 2025 Update
Intellia Therapeutics Inc.
NASDAQ: NTLA
NTLA Trading
0.03% G/L:
$12.73 Last:
1,289,650 Volume:
$13.02 Open:
NTLA Latest News
March 03, 2026 07:30:00 am
Intellia Therapeutics Presents Longer-Term Clinical Data for Lonvoguran Ziclumeran (lonvo-z); Hereditary Angioedema (HAE) Patient-Focused Research at AAAAI 2026
March 02, 2026 07:30:00 am
Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE Phase 3 Clinical Trial in ATTR-CM
NTLA Stock Data
$1,420,074,893
112,239,198
1.45%
105
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
